346 related articles for article (PubMed ID: 33358111)
1. Targeting the Mevalonate Pathway in Cancer.
Juarez D; Fruman DA
Trends Cancer; 2021 Jun; 7(6):525-540. PubMed ID: 33358111
[TBL] [Abstract][Full Text] [Related]
2. Secretion of apolipoprotein E by brain glia requires protein prenylation and is suppressed by statins.
Naidu A; Xu Q; Catalano R; Cordell B
Brain Res; 2002 Dec; 958(1):100-11. PubMed ID: 12468034
[TBL] [Abstract][Full Text] [Related]
3. Statins inhibit blastocyst formation by preventing geranylgeranylation.
Alarcon VB; Marikawa Y
Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
[TBL] [Abstract][Full Text] [Related]
4. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.
Yeganeh B; Wiechec E; Ande SR; Sharma P; Moghadam AR; Post M; Freed DH; Hashemi M; Shojaei S; Zeki AA; Ghavami S
Pharmacol Ther; 2014 Jul; 143(1):87-110. PubMed ID: 24582968
[TBL] [Abstract][Full Text] [Related]
5. The mevalonate synthesis pathway as a therapeutic target in cancer.
Andela VB; Pirri M; Schwarz EM; Puzas EJ; O'Keefe RJ; Rosenblatt JD; Rosier RN
Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S59-66. PubMed ID: 14600593
[TBL] [Abstract][Full Text] [Related]
6. Efficient use of exogenous isoprenols for protein isoprenylation by MDA-MB-231 cells is regulated independently of the mevalonate pathway.
Onono F; Subramanian T; Sunkara M; Subramanian KL; Spielmann HP; Morris AJ
J Biol Chem; 2013 Sep; 288(38):27444-27455. PubMed ID: 23908355
[TBL] [Abstract][Full Text] [Related]
7. Novel aspects of mevalonate pathway inhibitors as antitumor agents.
Thurnher M; Nussbaumer O; Gruenbacher G
Clin Cancer Res; 2012 Jul; 18(13):3524-31. PubMed ID: 22529099
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of geranylgeranylation mediates sensitivity to CHOP-induced cell death of DLBCL cell lines.
Ageberg M; Rydström K; Lindén O; Linderoth J; Jerkeman M; Drott K
Exp Cell Res; 2011 May; 317(8):1179-91. PubMed ID: 21324313
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer.
Göbel A; Zinna VM; Dell'Endice S; Jaschke N; Kuhlmann JD; Wimberger P; Rachner TD
BMC Cancer; 2020 Jul; 20(1):703. PubMed ID: 32727400
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of geranylgeranylation mediates the effects of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors on microglia.
Bi X; Baudry M; Liu J; Yao Y; Fu L; Brucher F; Lynch G
J Biol Chem; 2004 Nov; 279(46):48238-45. PubMed ID: 15364922
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin inhibits TGFβ1-induced fibronectin in human airway fibroblasts.
Schaafsma D; McNeill KD; Mutawe MM; Ghavami S; Unruh H; Jacques E; Laviolette M; Chakir J; Halayko AJ
Respir Res; 2011 Aug; 12(1):113. PubMed ID: 21864337
[TBL] [Abstract][Full Text] [Related]
12. Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer.
Graaf MR; Richel DJ; van Noorden CJ; Guchelaar HJ
Cancer Treat Rev; 2004 Nov; 30(7):609-41. PubMed ID: 15531395
[TBL] [Abstract][Full Text] [Related]
13. Mevalonate Cascade Inhibition by Simvastatin Induces the Intrinsic Apoptosis Pathway via Depletion of Isoprenoids in Tumor Cells.
Alizadeh J; Zeki AA; Mirzaei N; Tewary S; Rezaei Moghadam A; Glogowska A; Nagakannan P; Eftekharpour E; Wiechec E; Gordon JW; Xu FY; Field JT; Yoneda KY; Kenyon NJ; Hashemi M; Hatch GM; Hombach-Klonisch S; Klonisch T; Ghavami S
Sci Rep; 2017 Mar; 7():44841. PubMed ID: 28344327
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of farnesyl pyrophosphate (FPP) and/or geranylgeranyl pyrophosphate (GGPP) biosynthesis and its implication in the treatment of cancers.
Waller DD; Park J; Tsantrizos YS
Crit Rev Biochem Mol Biol; 2019 Feb; 54(1):41-60. PubMed ID: 30773935
[TBL] [Abstract][Full Text] [Related]
15. Statins, Mevalonate Pathway and its Intermediate Products in Placental Development and Preeclampsia.
Ermini L; Post M; Caniggia I
Curr Mol Pharmacol; 2017; 10(2):152-160. PubMed ID: 26758951
[TBL] [Abstract][Full Text] [Related]
16. Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease.
Hashemi M; Hoshyar R; Ande SR; Chen QM; Solomon C; Zuse A; Naderi M
Curr Mol Pharmacol; 2017; 10(1):13-26. PubMed ID: 26758949
[TBL] [Abstract][Full Text] [Related]
17. Statin-induced depletion of geranylgeranyl pyrophosphate inhibits cell proliferation by a novel pathway of Skp2 degradation.
Vosper J; Masuccio A; Kullmann M; Ploner C; Geley S; Hengst L
Oncotarget; 2015 Feb; 6(5):2889-902. PubMed ID: 25605247
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin-mediated enhancement of long-term potentiation is driven by farnesyl-pyrophosphate depletion and inhibition of farnesylation.
Mans RA; McMahon LL; Li L
Neuroscience; 2012 Jan; 202():1-9. PubMed ID: 22192838
[TBL] [Abstract][Full Text] [Related]
19. Key Enzymes for the Mevalonate Pathway in the Cardiovascular System.
Zhang C; Jin DD; Wang XY; Lou L; Yang J
J Cardiovasc Pharmacol; 2021 Feb; 77(2):142-152. PubMed ID: 33538531
[TBL] [Abstract][Full Text] [Related]
20. Mevalonate Pathway Regulates Cell Size Homeostasis and Proteostasis through Autophagy.
Miettinen TP; Björklund M
Cell Rep; 2015 Dec; 13(11):2610-2620. PubMed ID: 26686643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]